Neutroval

Active Ingredient(s): Tbo filgrastim
FDA Approved: * August 29, 2012
Pharm Company: * SICOR BIOTECH
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Neutroval Overview

2D9Q, 1CD9, 1GNC, 1PGR, 1RHGIdentifiersAliasesCSF3, C17orf33, CSF3OS, GCSF, colony stimulating factor 3External IDsOMIM: 138970 MGI: 1339751 HomoloGene: 7677 GeneCards: CSF3 Gene location (Human)Chr.Chromosome 17 (human)[1]Band17q21.1Start40,015,361 bp[1]End40,017,813 bp[1]Gene location (Mouse)Chr.Chromosome 11 (mouse)[2]Band11 D|11 62.45 cMStart98,701,263 bp[2]End98,703,629 bp[2]RNA expre...

Read more Neutroval Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Granulocyte_colony-stimulating_factor

Recent Neutroval Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tbo filgrastim
  • Injection: 300mcg/0.5ml, 480mcg/0.8ml, 5mcg/kg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Tbo filgrastim or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA